Possible association between acetazolamide administration during pregnancy and metabolic disorders in the newborn.
Development of metabolic acidosis, hypocalcemia and hypomagnesemia in a preterm infant whose mother was treated with acetazolamide throughout pregnancy is described. These neonatal metabolic alterations possibly related to acetazolamide administration in pregnancy have not been previously described in the literature. The metabolic acidosis was transient and resolved spontaneously despite breast feeding and continued administration of acetazolamide to the mother. Hypocalcemia and hypomagnesemia resolved quickly with appropriate treatment with calcium gluconate and magnesium sulphate, respectively. At follow-up at ages 1, 3 and 8 months, the baby showed mild hypertonicity of the lower limbs requiring physiotherapy.
Merlob
P
P
Department of Neonatology, Beilinson Medical Center, Petah Tikva, Israel.
Litwin
A
A
Mor
N
N
D000086:Acetazolamide / Q000009:adverse effects*; D000138:Acidosis / Q000139:chemically induced; D000328:Adult; D005260:Female; D006801:Humans; D006996:Hypocalcemia / Q000139:chemically induced; D007231:Infant, Newborn; D008274:Magnesium / Q000097:blood; D008659:Metabolic Diseases / Q000139:chemically induced*; D011247:Pregnancy; D011297:Prenatal Exposure Delayed Effects
D008274:Magnesium; D000086:Acetazolamide